| Application no. and date | 20737928.0 (espacenet) (Federated) (European Patent Register), 20200107 | | Patent/reg. no. and date | DK/EP 3908270, 20250827 | | Publication date | 20211117 | | Priority no. and date | US 201962789431 P, 20190107, US 201962789488 P, 20190107, US 201962789451 P, 20190107, US 201962789446 P, 20190107 | | EP pub. no. and date |
EP 3908270 20211117 | | Effective date | | | Applicant/owner | Antecip Bioventures II LLC, 630 Fifth Avenue, Suite 2000
New York, NY 10111, US | | Applicant ref. no. | P87035DK01 | | Inventor | TABUTEAU, Herriot, 22 Cortlandt Street, 16th Floor
New York, New York 10007, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/485 (2006.01) , A61P 25/24 (2006.01) | | Title | KOMBINATION AF DEXTROMETHORPHAN OG BUPROPION TIL BEHANDLING AF DEPRESSION HOS ASIATISKE PATIENTER | | Int. application no. | US2020012612 | | Int. publication no. | WO2020146412 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
